Shares of Owens & Minor OMI fell 0.61% in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share increased 305.00% year over year to $0.81, which beat the estimate of $0.67.
Revenue of $2,188,000,000 decreased by 8.80% from the same period last year, which beat the estimate of $2,080,000,000.
Guidance
The upcoming fiscal year's EPS expected to be between $1.90 and $2.00.
Owens & Minor hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Nov 02, 2020
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/muixea9t
Recent Stock Performance
Company's 52-week high was at $27.75
Company's 52-week low was at $3.63
Price action over last quarter: Up 81.75%
Company Profile
Owens & Minor distributes consumable medical supplies to a variety of providers. The company operates in two segments that are Global products and Global Solutions. The company offers a portfolio of products and services to healthcare providers and manufacturers in the Global solutions segment. In the Global product segment, the company manufactures and sources medical-surgical products through our production and kitting operations. The majority of the revenue is generated from the Global solutions segment. The company operates in Asia, Europe, Latin America, and the United States, while the majority of revenue comes from the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
